+

WO2002003910A3 - Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation - Google Patents

Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation Download PDF

Info

Publication number
WO2002003910A3
WO2002003910A3 PCT/RU2001/000276 RU0100276W WO0203910A3 WO 2002003910 A3 WO2002003910 A3 WO 2002003910A3 RU 0100276 W RU0100276 W RU 0100276W WO 0203910 A3 WO0203910 A3 WO 0203910A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
liquid
immunomoduling
anticancerogenic
antibacterial
Prior art date
Application number
PCT/RU2001/000276
Other languages
French (fr)
Russian (ru)
Other versions
WO2002003910A2 (en
Inventor
Raisa Ivanovna Yakubovskaya
Anna Vladimirovna Boyko
Elena Romanovna Nemtsova
Nadezhda Anatolievna Osipova
Tatyana Vladimirovna Sergeeva
Valery Ivanovich Chissov
Original Assignee
Raisa Ivanovna Yakubovskaya
Anna Vladimirovna Boyko
Elena Romanovna Nemtsova
Nadezhda Anatolievna Osipova
Tatyana Vladimirovna Sergeeva
Valery Ivanovich Chissov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raisa Ivanovna Yakubovskaya, Anna Vladimirovna Boyko, Elena Romanovna Nemtsova, Nadezhda Anatolievna Osipova, Tatyana Vladimirovna Sergeeva, Valery Ivanovich Chissov filed Critical Raisa Ivanovna Yakubovskaya
Priority to AU2001277824A priority Critical patent/AU2001277824A1/en
Publication of WO2002003910A2 publication Critical patent/WO2002003910A2/en
Publication of WO2002003910A3 publication Critical patent/WO2002003910A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, in particular an antibacterial, antioxidant, detoxicating, immunomoduling and anticancerogenic preparation. The inventive preparation comprises human lactoperrin as an active agent and pharmaceutically acceptable additives used for production of medicaments, and/or medicaments containing the preparation and pharmaceutically acceptable additives, i.e.: a liquid for intravenous injection, a liquid for intracavitary or intravesical injection, a liquid for peroral injection, a liquid for treating a wound surface, a liquid for intranasal application or in the form of eye drops, an ointment, bolus for peroral application, a suppository for rectal and intravaginal application and pills. The inventive method can be used for preventing and curing diseases with the aid of the preparation containing the human lactoferrin. The invention makes it possible to develop a preparation and a medicament based thereon for a moderate cost.
PCT/RU2001/000276 2000-07-13 2001-07-09 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation WO2002003910A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001277824A AU2001277824A1 (en) 2000-07-13 2001-07-09 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2000118424/14A RU2165769C1 (en) 2000-07-13 2000-07-13 Antibacterial, antioxidant, immunomodulating and anticancer preparation and method of its embodiment
RU2000118424 2000-07-13

Publications (2)

Publication Number Publication Date
WO2002003910A2 WO2002003910A2 (en) 2002-01-17
WO2002003910A3 true WO2002003910A3 (en) 2002-06-20

Family

ID=20237690

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2001/000276 WO2002003910A2 (en) 2000-07-13 2001-07-09 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation

Country Status (3)

Country Link
AU (1) AU2001277824A1 (en)
RU (1) RU2165769C1 (en)
WO (1) WO2002003910A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399570B1 (en) 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
RU2194501C1 (en) * 2001-06-18 2002-12-20 Государственное образовательное учреждение высшего профессионального образования Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Method for increasing a bladder's reservoir function at chronic cystitis
ATE519499T1 (en) 2002-05-10 2011-08-15 Agennix Inc LACTOFERRIN IN THE TREATMENT OF MALIGNANT NEOPLASIA AND OTHER HYPERPROLIFERATIVE DISEASES
JP4516844B2 (en) 2002-09-16 2010-08-04 エイジェニックス インコーポレイテッド Lactoferrin in wound treatment
AU2003296447A1 (en) 2002-12-10 2004-06-30 Agennix Incorporated Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
US7323443B2 (en) 2002-12-12 2008-01-29 Agennix Inc. Lactoferrin in the reduction of pain
WO2004103285A2 (en) 2003-05-14 2004-12-02 Agennix Incorporated Lactoferrin in the treatment of diabetes mellitus
AU2004289170B2 (en) 2003-06-06 2009-12-17 Agennix Incorporated Lactoferrin as an adjuvant in cancer vaccines
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
RU2360678C1 (en) * 2008-01-30 2009-07-10 Сергей Георгиевич Павленко Wound surface healing technique
RU2421192C1 (en) * 2010-03-09 2011-06-20 Винера Гумаровна Нафикова Method of treating chronic bacterial conjunctivitis
BR112013012811B8 (en) 2010-11-26 2022-07-05 Evonik Roehm Gmbh PEPTIDE DERIVED FROM HUMAN LACTOFERRIN, AND PROCESS FOR PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR RELEASE OF A BIOLOGICAL ACTIVE SUBSTANCE IN A MAMMALIAN ORGANISM
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
RU2488406C1 (en) * 2012-02-16 2013-07-27 Общество с ограниченной ответственностью "НТфарма" Pharmaceutical composition for therapy of acute toxic conditions
RU2687969C1 (en) * 2018-03-02 2019-05-17 Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук Antimicrobial agent

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543392A (en) * 1992-07-29 1996-08-06 Morinaga Milk Industry Co., Ltd. Digestive tract cell activating agent of EGF and lactoferrin
RU95102930A (en) * 1995-02-28 1997-06-10 Московский научно-исследовательский онкологический институт им.П.А.Герцена Agent for rheumatic arthritis treatment
RU2099065C1 (en) * 1994-09-23 1997-12-20 Московский научно-исследовательский онкологический институт им. П.А.Герцена МЗ РФ Preparation and method for treating local complications occurring during conservative antitumoral treatment in oropharyngeal zone
WO1998044940A1 (en) * 1997-04-10 1998-10-15 Agennix, Inc. Use of lactoferin in the treatment of allergen induced disorders
EP0955058A1 (en) * 1997-01-09 1999-11-10 Morinaga Milk Industry Co., Ltd. Lactoferrin tablets

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294018A1 (en) * 1998-04-13 1999-10-21 New England Medical Center Hospitals, Inc. Methods and compositions for inactivating infectious agents using lactoferrin and related molecules

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543392A (en) * 1992-07-29 1996-08-06 Morinaga Milk Industry Co., Ltd. Digestive tract cell activating agent of EGF and lactoferrin
RU2099065C1 (en) * 1994-09-23 1997-12-20 Московский научно-исследовательский онкологический институт им. П.А.Герцена МЗ РФ Preparation and method for treating local complications occurring during conservative antitumoral treatment in oropharyngeal zone
RU95102930A (en) * 1995-02-28 1997-06-10 Московский научно-исследовательский онкологический институт им.П.А.Герцена Agent for rheumatic arthritis treatment
EP0955058A1 (en) * 1997-01-09 1999-11-10 Morinaga Milk Industry Co., Ltd. Lactoferrin tablets
WO1998044940A1 (en) * 1997-04-10 1998-10-15 Agennix, Inc. Use of lactoferin in the treatment of allergen induced disorders

Also Published As

Publication number Publication date
AU2001277824A1 (en) 2002-01-21
RU2165769C1 (en) 2001-04-27
WO2002003910A2 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
WO2002003910A3 (en) Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
WO2002017881A3 (en) Transdermal pharmaceutical delivery composition
EP1576963A3 (en) Use of botulinum toxin in the treatment of pain due to an infection
WO2003039436A3 (en) Pharmaceutical compositions containing oxybutynin
IL171607A (en) Use of a botulinum toxin for the preparation of a medicament for treating sinus headache
WO2008062440A3 (en) Programmable buoyant delivery technology
EP1772767A3 (en) Method for forming contact lenses comprising therapeutic agents
BR0109875A (en) Treatment of respiratory diseases
WO2003059318A3 (en) Medicated tampon
EP1283054A4 (en) Drugs for complications of diabetes and neuropathy and utilization thereof
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
WO2007075695A3 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
CA2454976A1 (en) Therapeutic agent for glaucoma comprising compound having pi3 kinase inhibitory action as active ingredient
WO2001030380A3 (en) Methods and compositions for treatment of keratoconus using protease inhibitors
AU2002211536A1 (en) Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
WO2001091774A3 (en) Method of treating chronic ulcers
WO2005094836A3 (en) Use of loteprednol etabonate for the treatment of dry eye
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
WO2001024783A3 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
WO2001081332A3 (en) 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance
WO2002053090A3 (en) Medicinal association of a biguanine (metformin) and arginine
WO2006050002A3 (en) Compositions for controlled delivery of pharmaceutically active compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载